• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Precigen, Inc. - Common Stock (NQ:PGEN)

6.100 -0.390 (-6.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,960,242
Open 6.320
Bid (Size) 6.090 (300)
Ask (Size) 6.160 (1,000)
Prev. Close 6.490
Today's Range 6.080 - 6.395
52wk Range 1.804 - 7.320
Shares Outstanding 252,419,690
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Precigen (PGEN) Q2 2026 Earnings Call Transcript ↗
August 11, 2026
PAPZIMEOS revenue surged 145.8% sequentially as company posts first profitable quarter. 
Via The Motley Fool
Topics Earnings
News headline image
Precigen Q2 Earnings Call Highlights ↗
August 04, 2026
Precigen (NASDAQ:PGEN) reported a sharp increase in second-quarter revenue from its PAPZIMEOS launch, with the company reaching quarterly profitability less than a year after the therapy’s August 2025... 
Via MarketBeat
Topics Earnings

Performance

YTD
+42.5%
+42.5%
1 Month
+19.1%
+19.1%
3 Month
+38.0%
+38.0%
6 Month
+23.7%
+23.7%
1 Year
+229.7%
+229.7%

More News

Read More
What's going on in today's after hours session ↗
August 04, 2026
Via Chartmill
Precigen Inc (NASDAQ:PGEN) Flashes Perfect Technical Rating and Explosive Sales Growth in Minervini Screen ↗
July 08, 2026
Via Chartmill
Precigen Inc (NASDAQ:PGEN) Stock Surges on Narrower Loss and Commercial Transition After FDA Approval ↗
March 25, 2026
Via Chartmill
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet? ↗
December 02, 2025
Via The Motley Fool
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Via Benzinga
News headline image
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors? ↗
July 15, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
June 15, 2026
Via ACCESS Newswire
News headline image
Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares? ↗
June 12, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Precigen Q1 Earnings Call Highlights ↗
May 14, 2026
Via MarketBeat
Topics Earnings
News headline image
Precigen (PGEN) Q1 2026 Earnings Transcript ↗
May 13, 2026
Via The Motley Fool
News headline image
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
April 07, 2026
Via ACCESS Newswire
News headline image
These Analysts Boost Their Forecasts On Precigen Following Q4 Results ↗
March 26, 2026
Via Benzinga
Thursday's session: gap up and gap down stocks ↗
March 26, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday. ↗
March 26, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
March 25, 2026
Via Chartmill
News headline image
Precigen (PGEN) Q4 2025 Earnings Call Transcript ↗
March 25, 2026
Via The Motley Fool
Topics Earnings
News headline image
Inside One Fund's $21 Million Bet on Hilton Grand Vacations Stock ↗
January 24, 2026
Via The Motley Fool
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
November 14, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
November 14, 2025
Via Benzinga
News headline image
Precigen Inc (NASDAQ:PGEN) Q3 2025 Earnings: Revenue Soars But Wider Loss Dampens Investor Sentiment ↗
November 13, 2025
Via Chartmill
News headline image
Precigen (PGEN) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
Via The Motley Fool
Topics Earnings
News headline image
Exploring Precigen's Earnings Expectations ↗
November 12, 2025
Via Benzinga
News headline image
Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares ↗
November 01, 2025
Via The Motley Fool

Frequently Asked Questions

Is Precigen, Inc. - Common Stock publicly traded?
Yes, Precigen, Inc. - Common Stock is publicly traded.
What exchange does Precigen, Inc. - Common Stock trade on?
Precigen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Precigen, Inc. - Common Stock?
The ticker symbol for Precigen, Inc. - Common Stock is PGEN on the Nasdaq Stock Market
What is the current price of Precigen, Inc. - Common Stock?
The current price of Precigen, Inc. - Common Stock is 6.100
When was Precigen, Inc. - Common Stock last traded?
The last trade of Precigen, Inc. - Common Stock was at 08/14/26 04:00 PM ET
What is the market capitalization of Precigen, Inc. - Common Stock?
The market capitalization of Precigen, Inc. - Common Stock is 1.54B
How many shares of Precigen, Inc. - Common Stock are outstanding?
Precigen, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap